References

Advancing therapy for neuroblastoma

10.1038/s41571-022-00643-z · 2022 · External reference

Expert consensus on diagnosis and treatment of pediatric neuroblastoma

10.3760/cma.j.issn.0253-3006.2015.01.002 · 2015 · External reference

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment

10.1200/jco.1993.11.8.1466 · 1993 · External reference

Infant cancer in the U.S.: histology-specific incidence and trends, 1973 to 1992

10.1097/00043426-199709000-00004 · 1997 · External reference

Neonatal Neuroblastoma

10.1016/j.clp.2020.11.006 · 2021 · External reference

Fetal neuroblastoma: prenatal diagnosis and natural history

10.1016/0022-3468(93)90157-g · 1993 · External reference

Features and outcomes of neonatal neuroblastoma

10.1007/s00383-011-2937-x · 2011 · External reference

Cystic neuroblastoma of infancy

10.1016/0022-3468(95)90504-9 · 1995 · External reference

A rare case of congenital orbital cystic neuroblastoma in an infant

10.1159/000490476 · 2019 · External reference

Presacral cystic neuroblastoma: case report and review of the literature

10.1097/01.mph.0000212975.36619.c7 · 2006 · External reference

Perinatal neuroblastoma

10.1053/j.sempedsurg.2005.11.003 · 2006 · External reference

Single-cell transcriptomic analyses provide insights into the developmental origins of neuroblastoma

10.1038/s41588-021-00806-1 · 2021 · External reference

Unresolved reference

2023 · External reference

PHOX2B immunolabeling: a novel tool for the diagnosis of undifferentiated neuroblastomas among childhood small round blue-cell tumors

10.1097/pas.0b013e31825a6895 · 2012 · External reference

Diagnostic utility of PHOX2B in primary and treated neuroblastoma and in neuroblastoma metastatic to the bone marrow

10.5858/arpa.2014-0255-oa · 2015 · External reference

Prognostic subgroups for undifferentiated neuroblastoma: immunohistochemical study with anti-S-100 protein antibody

10.1016/s0046-8177(85)80085-x · 1985 · External reference

Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage

10.1126/science.6719137 · 1984 · External reference

Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas

10.1056/nejm198510313131802 · 1985 · External reference

Neuroblastoma, version 2.2024, NCCN clinical practice guidelines in oncology

10.6004/jnccn.2024.0040 · 2024 · External reference

Revised neuroblastoma risk classification system: a report from the children's oncology group

10.1200/jco.21.00278 · 2021 · External reference

Chromosome 1p and 11q deletions and outcome in neuroblastoma

10.1056/nejmoa052399 · 2005 · External reference

Age dependency of the prognostic impact of tumor genomics in localized resectable MYCN nonamplified neuroblastomas. Report from the SIOPEN biology group on the LNESG trials and a COG validation group

10.1200/jco.18.02132 · 2020 · External reference

Cancer risks in first-degree relatives of CHEK2 mutation carriers: effects of mutation type and cancer site in proband

10.1038/sj.bjc.6605038 · 2009 · External reference

Two cases of neuroblastoma comprising two distinct clones

10.1002/pbc.24779 · 2014 · External reference

A case of composite neuroblastoma composed of histologically and biologically distinct clones

10.2350/06-06-0117.1 · 2007 · External reference

Composite neuroblastoma metastatic to a lymph node: the novel histopathologic diagnosis of a unique multiclonal neoplasm

2021 · External reference

Revision of the international neuroblastoma pathology classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular

10.1002/cncr.11773 · 2003 · External reference

Long-term follow-up of the "wait and see" approach to localized perinatal adrenal neuroblastoma

10.1007/s00268-012-1837-0 · 2013 · External reference